Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

RNAZ Stock Forecast, Price Targets, Chart, Dividends & Analysis

TransCode Therapeutics Inc

Sector: Professional, Scientific, and Technical Services   

Industry: Research and Development in Biotechnology

3.76
 
USD
  
-0.09
  
(-2.34%)
Previous close: 3.85  Open: 3.82  Bid: 3.76  Ask: 3.85
52 week range    
3.21   
   264.00
Mkt Cap: 4 M  Avg Vol (90 Days): 57,319
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

42
MarketXLS Rank
80
Value
23
Technical
23
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

RNAZ Income Statement

Annual
Invalid dateDec-21Dec-22Dec-23
Basic EPS from continuing operations-21384.0-35640.0-3419.13
Basic EPS total-21384.0-35640.0-3419.13
Basic weighted shares outstanding319.0491.05424.0
Depreciation42470.098606.0123483.0
DepreciationAndAmortization42470.098606.0123483.0
Diluted EPS total-21384.0-35640.0-3419.13
Diluted normalized net income/share-21384.0-35640.0-3419.13
Diluted weighted shares outstanding319.0491.05424.0
GainOnSaleOfPPE-3082.0
GainOnSaleOfSecurity-867000.0
GeneralAndAdministrativeExpense3 M8 M7 M
Income before tax-7 M-18 M-19 M
Income restructuring and M&A424576.0
Income taxes53051.0
Interest income664.020410.05285.0
InterestExpenseNonOperating95070.031986.055899.0
MiscOtherSpecialCharges-594776.01 M923035.0
Net income from total operations-7 M-18 M-19 M
NetIncomeCommonStockholders-7 M-18 M-19 M
NetIncomeContinuousOperations-7 M-18 M-19 M
NetNonOperatingInterestIncomeExpense-94406.011576.0-50614.0
Normalized income-5 M-14 M
Operating income-6 M-19 M-19 M
Operating income before depreciation (EBITDA)-7 M-17 M-18 M
OperatingExpense6 M18 M18 M
Other income net597858.0-1 M-923035.0
OtherGandA3 M8 M7 M
OtherOperatingExpenses-125000.0
RentAndLandingFees-3105.0
Research & development expense3 M10 M12 M
ResearchExpense3 M10 M12 M
RestructringAndMnAIncome424576.0
Selling Gen & administrative expense3 M8 M7 M
Special income/charges-424576.0
Total Income available for interest expense (EBIT)-7 M-18 M-18 M
Total common shares outstanding488.0599.06 M
Total net income-7 M-18 M-19 M
Total ordinary shares696233.0696233.0696233.0
TotalExpenses6 M18 M18 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University